Skip to main content

Table 2 Clinical and demographic data.

From: Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

 

FE

<10 yr

10 to 20 yr

>20 yr

p

Age

25.7 (± 8.2)

29.0 (± 7.5)

39.0 (± 6.1)

49.8 (± 5.8)

0.0001

Sex

    

ns

Female

26% (26)

33.1% (43)

40.0% (36)

39.2% (26)

 

Male

74% (74)

66.9% (87)

66.0% (70)

60.8% (74)

 

GAF

58.4 (± 10.8)

61.9 (± 7.5)

61.7 (± 9.0)

59.7 (± 8.9)

 

Age first admission

25.2 (± 8.2)

23.8 (± 7.1)

24.2 (± 5.7)

22.2 (± 4.1)

0.0277

N admissions

1.6 (± 1.2)

3.9 (± 2.2)

6.8 (± 4.0)

9.0 (± 6.1)

0.0001

Duration illness

0.5 (± 0.4)

5.2 (± 2.4)

14.8 (± 2.8)

27.6 (± 5.7)

0.0001

N pills

2.1 (± 1.0)

2.8 (± 1.4)

3.8 (± 2.4)

4.2 (± 2.2)

0.0001

BMI

23.7 (± 1.3)

25.9 (± 5.2)

27.2 (± 5.3)

26.6 (± 5.0)

0.0001

BMI segmentation

    

0.0001

Normal

68% (68)

44.6% (58)

38.7% (41)

36.7% (29)

 

Overweight

23% (23)

40.0% (52)

32.1% (34)

41.8% (33)

 

Obese

9% (9)

15.4% (20)

29.2% (31)

21.5% (20)

 

Living situation

    

0.0001

Sheltered housing

1% (1)

11.5% (15)

20.8% (22)

24.0% (19)

 

With family

48% (48)

32.3% (42)

14.1% (15)

12.7% (10)

 

Partner

14% (14)

7.7% ()10

7.6% (8)

15.2% (12)

 

Alone

31% (31)

26.9% (35)

26.4% (28)

17.7% (14)

 

Residential facility

6% (6)

21.6% (28)

31.1% (33)

30.4% (24)

 

Occupation

    

0.0001

Work

11% (11)

3.0% (4)

6.6% (7)

7.6% (6)

 

Sheltered work

0% (0)

0.8% (1)

4.7% ()5

1.3% (1)

 

Study/training

25% (25)

15.4% (20)

10.4% (11)

1.3% (1)

 

None

64% (64)

80.8% (105)

78.3% (83)

89.9% (71)

 

Family history CVD

45% (45)

42.3% (55)

51.8% (55)

53.2% (45)

ns

Family history Diabetes

32% (32)

23.1% (30)

35.8% (38)

36.7% (29)

ns

Family history lipid disorder

34% (34)

36.1% (47)

36.8% (39)

30.4% (24)

ns